Related Experiment Video
Updated: Apr 15, 2026

Author Spotlight: Improving Lesion Contiguity in Pulmonary Vein Isolation via Proactive Esophageal Cooling
Published on: April 19, 2024
High Atrial Defibrillation Threshold With Internal Cardioversion Indicates Arrhythmogenicity of Superior Vena Cava in
Kensuke Ihara1, Takeshi Sasaki, Yasuhiro Shirai
1Department of Cardiovascular Medicine, Tokyo Medical and Dental University.
Insights
High internal cardioversion atrial defibrillation threshold (ADFT) is linked to superior vena cava (SVC) arrhythmogenicity in patients with non-long-standing persistent atrial fibrillation (AF). This finding is crucial for understanding AF ablation outcomes.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Atrial fibrillation (AF) ablation is a common procedure.
- Understanding factors influencing ablation success is critical.
- The role of the superior vena cava (SVC) in AF and cardioversion requires further clarification.
Purpose of the Study:
- To investigate the relationship between atrial defibrillation threshold (ADFT) during internal cardioversion (IC) and the arrhythmogenic potential of the SVC.
- To determine if SVC arrhythmogenicity impacts cardioversion success in AF patients.
Main Methods:
- Radiofrequency catheter ablation for AF was performed in 159 patients.
- Internal cardioversion (IC) using a specialized catheter was conducted in 50 patients with non-long-standing persistent AF (non-LSAF).
- SVC arrhythmogenicity was defined by SVC firing initiating or maintaining AF, or frequent SVC ectopy.
Main Results:
- AF termination was achieved in 49 out of 50 non-LSAF patients during IC.
- SVC arrhythmogenicity was significantly more frequent in patients with ADFT >10 J compared to those with ADFT ≤10 J (60% vs. 13%, P=0.004).
- Patients undergoing SVC isolation had a higher ADFT before isolation than those who did not (15.5±8.8 J vs. 9.2±4.4 J, P=0.01).
Conclusions:
- A high internal cardioversion atrial defibrillation threshold (ADFT) is associated with superior vena cava (SVC) arrhythmogenicity in non-long-standing persistent AF patients.
- SVC arrhythmogenicity may be a relevant factor in patients requiring higher energy for cardioversion.
- These findings may inform strategies for AF ablation and cardioversion.
Background:
The purpose of this study was to clarify the relation between atrial defibrillation threshold (ADFT) for internal cardioversion (IC) and arrhythmogenicity of the superior vena cava (SVC).
Methods And Results:
A total of 159 consecutive patients (139 male, age 59.9±10.3 years) who underwent radiofrequency catheter ablation of atrial fibrillation (AF) were assessed. IC was performed in 50 patients with non-long-standing persistent AF (non-LSAF) with a purpose-built cardioversion catheter in which direct current is delivered between the right atrium and the coronary sinus. SVC arrhythmogenicity was defined as SVC firing initiating AF, SVC associated with maintenance of AF, or frequent ectopy in the SVC. In all 50 non-LSAF patients, AF termination was obtained on IC during the procedure except in 1 patient with SVC AF. In the patients with ADFT >10 J (n=10), SVC arrhythmogenicity was observed more often than in those with ADFT ≤10 J (n=40; 60% vs. 13%; P=0.004). There were no significant differences between the 2 groups in left atrial diameter (40.8±7.6 vs. 40.6±6.3 mm; P=0.92), persistent AF (33% vs. 50%; P=0.46), or other clinical parameters. The patients who underwent SVC isolation, however, had higher ADFT before SVC isolation than those who did not (15.5±8.8 vs. 9.2±4.4 J; P=0.01).
Conclusions:
High IC ADFT is associated with SVC arrhythmogenicity in non-LSAF patients.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias

